Finance

Lists
BDSX:NASDAQ
Biodesix Inc
27,72 $
+1,43%
(+0,39) 1D
28,27 $
+1,98% (+0,55)
After hours
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDSX...
Open
27,55 $
High
28,72 $
Low
26,96 $
Mkt. cap
292,48 մլն
Avg. vol.
119,28 հզր
Volume
124,34 հզր
52-wk high
31,97 $
52-wk low
5,26 $
EPS
-3,17 $
Beta
0,56
Shares outstanding
10,55 մլն
No. of employees
334
Open
27,55 $
High
28,72 $
Low
26,96 $
Mkt. cap
292,48 մլն
Avg. vol.
119,28 հզր
Volume
124,34 հզր
52-wk high
31,97 $
52-wk low
5,26 $
EPS
-3,17 $
Beta
0,56
Shares outstanding
10,55 մլն
No. of employees
334
News stories
From web sources and news partners
About Biodesix Inc
CEO-
Employees334
Founded2005
HeadquartersLouisville, Կոլորադո, Միացյալ Նահանգներ
SectorHealth care provider
Websitebiodesix.com
Analyst ratings
Based on 7 analysts giving stock ratings to BDSX in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for BDSX in the last 3 months.
Highest
Current 27,72 $
41,00 $ (+47,91%)
Average
37,33 $ (+34,67%)
Lowest
30,00 $ (+8,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
38,00 $
+37,1%
09/25/2026
Max Masucci
Roth MKM
Buy
Reiterated
41,00 $
+47,9%
09/25/2026
Thomas Flaten
Lake Street
Buy
Maintained
40,00 $
+44,3%
09/24/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Reiterated
35,00 $
+26,3%
08/10/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
30,00 $
+8,2%
08/06/2026
William Bonello
Craig-Hallum
Buy
Maintained
40,00 $
+44,3%
08/06/2026
Matt Larew
William Blair
Buy
Reiterated
-
-
08/06/2026
Unknown Analyst
Roth MKM
Buy
Initiated
32,00 $
+15,4%
06/24/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
21,77 մլն
28,76 մլն
25,56 մլն
26,86 մլն
Cost of goods sold
4,11 մլն
4,88 մլն
4,60 մլն
4,82 մլն
Cost of revenue
4,11 մլն
4,88 մլն
4,60 մլն
4,82 մլն
Research and development expenses
2,99 մլն
2,87 մլն
3,28 մլն
3,14 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21,71 մլն
22,97 մլն
24,26 մլն
24,28 մլն
Operating expense
24,71 մլն
25,84 մլն
27,55 մլն
27,42 մլն
Total operating expenses
28,81 մլն
30,72 մլն
32,15 մլն
32,24 մլն
Operating income
-7,04 մլն
-1,97 մլն
-6,60 մլն
-5,38 մլն
Other non operating income
409,00 հզր
46,00 հզր
385,00 հզր
-
EBT including unusual items
-8,72 մլն
-3,98 մլն
-7,79 մլն
-7,27 մլն
EBT excluding unusual items
-8,71 մլն
-3,98 մլն
-8,19 մլն
-7,26 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,72 մլն
-3,98 մլն
-7,79 մլն
-7,27 մլն
Net profit margin
-40,04%
-13,84%
-30,50%
-27,08%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
97,00 հզր
Interest expense
-2,07 մլն
-2,06 մլն
-1,98 մլն
-1,98 մլն
Net interest expenses
-2,07 մլն
-2,06 մլն
-1,98 մլն
-1,88 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,64 մլն
-579,00 հզր
-5,20 մլն
-3,99 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps